In a Bloomberg Law article, health care partner Mark Barnes commented on new clinical trial diversity requirements that can assist panels charged with ethics reviews of human studies.
All research must pass a review by an ethics panel known as an institutional review board if the study involves human subjects and is either FDA-regulated or federally funded.
Mark expects IRBs would be influenced by guidance that the U.S. Food and Drug Administration would produce on the issue of enhancing opportunities for more equitable enrollment in clinical trials.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.